Chest Radiology: Page 6

France moves ahead with lung cancer screening strategy

By Dr. Caroline Caramella and Prof. Mathieu Lederlin

A novel lung cancer screening examination has been developed in France. This examination and issues associated with rolling out population-based lung cancer screening have prompted intense discussion as the first pilot studies are initiated.

October 16, 2022

Attention shifts to PET/CT use in cases of non-small cell lung cancer

By Philip Ward

A multinational team of researchers has taken steps to boost radiologists' understanding of how best to use PET/CT and optimize techniques in patients with non-small cell lung cancer.

October 11, 2022

Brainomix to collaborate with U.K. government on AI for lung cancer

By AuntMinnieEurope.com staff writers

U.K. artificial intelligence (AI) software developer Brainomix plans to collaborate with the National Consortium of Intelligent Medical Imaging (NCIMI) on a 12-month project to validate its automated cancer tracking tool, e-ACT.

October 9, 2022

Video from JFR 2022: Rémy-Jardin on photon-counting CT's promise

PARIS - There is well-deserved excitement around photon-counting CT and the technology will have important clinical implications, Prof. Martine Rémy-Jardin said in an exclusive interview with AuntMinnieEurope.com at the JFR, the annual meeting of the French Society of Radiology.

October 9, 2022

Oxipit secures Lithuanian ChestLink contract

By AuntMinnieEurope.com staff writers

Oxipit has installed its ChestLink artificial intelligence software in a Lithuanian health clinic.

October 3, 2022

U.K. issues guidance on alerts for imaging reports

By AuntMinnieEurope.com staff writers

The U.K. Royal College of Radiologists (RCR) has released recommendations on alerts and notifications for imaging reports.

October 2, 2022

Optellum finalizes series A funding round

By AuntMinnieEurope.com staff writers

Artificial intelligence software developer Optellum has received $14 million (15 million euros) in a series A funding round.

September 26, 2022

German insurance authorities clarify COVID-19 coverage

By AuntMinnieEurope.com staff writers

COVID-19 can be classified as an "occupational disease" or an "accident at work" under certain circumstances, according to new guidance from Germany.

September 22, 2022

Low-field MRI proves value in monitoring COVID-19 lung damage

By Kate Madden Yee

Low-field MRI offers an alternative to CT for tracking persistent lung damage in children who have recovered from COVID-19 or have long COVID, German researchers have reported. They published their findings on 19 September in Radiology.

September 21, 2022

Brainomix, Bridge Biotherapeutics partner

By AuntMinnieEurope.com staff writers

U.K. artificial intelligence software developer Brainomix and Bridge Biotherapeutics have partnered to deliver imaging biomarker analysis in a study that is testing Bridge's autotaxin inhibitor BBT-877 as a treatment for idiopathic pulmonary fibrosis.

September 6, 2022

German study shows dark-field chest x-ray differentiates lung disease

By Will Morton

Investigators from Munich have concluded that their prototype dark-field chest x-ray system can help to distinguish between emphysema and fibrosis. They published a case report on 18 August in Radiology: Cardiothoracic Imaging.

August 22, 2022

IASLC: Air pollution exposure adds to lung cancer risk

By AuntMinnieEurope.com staff writers

Long-term exposure to air pollution should be considered a risk factor for lung cancer in patients who have never smoked, according to research presented on 9 August at the International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on Lung Cancer in Vienna, Austria.

August 8, 2022

Previous Page

Page 6 of 60

Next Page